Thrombelastogram in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery

NCT00778492 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2008-10-23

No results posted yet for this study

Summary

Study Objective is to correlate the results of preoperative platelet mapping derived from modified TEG with clinically significant postoperative bleeding and consumption of blood products.

Conditions

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Sergey Preisman, MD · Sheba Medical Center

  • Alexander Kogan, MD · Sheba Medical Center

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-10-31
Completion
2008-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00778492 on ClinicalTrials.gov